Literature DB >> 20926639

The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.

Kathleen McCaffrey1, Hamed Gouklani, Irene Boo, Pantelis Poumbourios, Heidi E Drummer.   

Abstract

The three variable regions of hepatitis C virus (HCV) glycoprotein E2 can be removed simultaneously from the E2 ectodomain (residues 384-661) without affecting folding or CD81 binding. In this study, we show that deletion of hypervariable region (HVR) 2 or the intergenotypic variable region (igVR) in the context of the E1E2 polyprotein eliminates formation of heterodimers, reduces CD81 binding and abolishes virus entry. The replication competence of genomic RNA transcribed from the JFH1 infectious HCV clone was not affected by the HVR1, HVR2 or igVR deletions in transfected Huh7.5 cells. However, infectivity of the resultant cell-culture-derived HCV (HCVcc) was abolished by HVR2 or igVR deletions, while deletion of HVR1 led to a 5- to 10-fold reduction in infectivity. Serial passage of cells transfected with genomes lacking HVR1 generated reverted viruses with wild-type levels of infectivity. Sequencing of viral cDNA obtained after full reversion revealed mutations in E1 (I262L) and E2 (N415D) that were present in 35 and 27 % of clones, respectively. Insertion of N415D into HVR1-deleted HCV genomes conferred wild-type levels of infectivity, while I262L increased infectivity by 2.5-fold. These results suggest that HVR2 and the igVR, but not HVR1, are essential for structural integrity and function of the HCV glycoprotein heterodimer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926639     DOI: 10.1099/vir.0.026385-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly.

Authors:  Melissanne de Wispelaere; Priscilla L Yang
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.

Authors:  Holly Freedman; Michael R Logan; Darren Hockman; Julia Koehler Leman; John Lok Man Law; Michael Houghton
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

Review 3.  Ultrastructural and biochemical basis for hepatitis C virus morphogenesis.

Authors:  Viviana Falcón; Nelson Acosta-Rivero; Sirenia González; Santiago Dueñas-Carrera; Gillian Martinez-Donato; Ivon Menéndez; Rocio Garateix; José A Silva; Emilio Acosta; Juan Kourı
Journal:  Virus Genes       Date:  2017-02-23       Impact factor: 2.332

4.  Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening.

Authors:  Jennifer M Pfaff-Kilgore; Edgar Davidson; Kathryn Kadash-Edmondson; Mayda Hernandez; Erin Rosenberg; Ross Chambers; Matteo Castelli; Nicola Clementi; Nicasio Mancini; Justin R Bailey; James E Crowe; Mansun Law; Benjamin J Doranz
Journal:  Cell Rep       Date:  2022-05-24       Impact factor: 9.995

5.  Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry.

Authors:  Thomas H R Carlsen; Troels K H Scheel; Santseharay Ramirez; Steven K H Foung; Jens Bukh
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

6.  Identification of new functional regions in hepatitis C virus envelope glycoprotein E2.

Authors:  Anna Albecka; Roland Montserret; Thomas Krey; Alexander W Tarr; Eric Diesis; Jonathan K Ball; Véronique Descamps; Gilles Duverlie; Felix Rey; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

7.  Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection.

Authors:  Rachael E Swann; Vanessa M Cowton; Mark W Robinson; Sarah J Cole; Stephen T Barclay; Peter R Mills; Emma C Thomson; John McLauchlan; Arvind H Patel
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

8.  Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a Infection.

Authors:  Yousef M O Alhammad; Sanvir Maharajh; Rebecca Butcher; John-Sebastian Eden; Peter A White; Pantelis Poumbourios; Heidi E Drummer
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

Review 9.  Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design.

Authors:  Alexander W Tarr; Tanvi Khera; Kathrin Hueging; Julie Sheldon; Eike Steinmann; Thomas Pietschmann; Richard J P Brown
Journal:  Viruses       Date:  2015-07-17       Impact factor: 5.048

Review 10.  Hepatitis C Virus Epitope Immunodominance and B Cell Repertoire Diversity.

Authors:  Nicholas A Brasher; Anurag Adhikari; Andrew R Lloyd; Nicodemus Tedla; Rowena A Bull
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.